Obesity and type 2 diabetes are associated with a state of abnormal inflammatory response. While this correlation has also been recognized in the clinical setting, its molecular basis and physiological significance are not yet fully understood. Studies in recent years have provided important insights into this curious phenomenon. The state of chronic inflammation typical of obesity and type 2 diabetes occurs at metabolically relevant sites, such as the liver, muscle, and most interestingly, adipose tissues. The biological relevance of the activation of inflammatory pathways became evident upon the demonstration that interference with these pathways improve or alleviate insulin resistance. The abnormal production of tumor necrosis factor alpha (TNF-a) in obesity is a paradigm for the metabolic significance of this inflammatory response. When TNF-a activity is blocked in obesity, either biochemically or genetically, the result is improved insulin sensitivity. Studies have since focused on the identification of additional inflammatory mediators critical in metabolic control and on understanding the molecular mechanisms by which inflammatory pathways are coupled to metabolic control. Recent years have seen a critical progress in this respect by the identification of several downstream mediators and signaling pathways, which provide the crosstalk between inflammatory and metabolic signaling. These include the discovery of c-Jun N-terminal kinase (JNK) and Ikappabkinase (IkK) as critical regulators of insulin action activated by TNF-a and other inflammatory and stress signals, and the identification of potential targets. Here, the role of the JNK pathway in insulin receptor signaling, the impact of blocking this pathway in obesity and the mechanisms underlying JNK-induced insulin resistance will be discussed.
Several cell types, such as adipocytes and macrophages, are involved in this abnormal cytokine production. This seemingly surprising ability of fat cells to mount an immune response is likely to be a function of its common features with macrophages 2 and critical in systemic insulin action. 3 Insulin signaling is a very complex process that involves multiple pathways and cascades of phosphorylation events. For the purposes of this short review, these pathways will not be described; however, readers could refer to excellent recent reviews on these pathways. 4, 5 Over the past decade, it is well established that insulin receptor signaling is defective at multiple levels in type 2 diabetes both in experimental models and humans and this defective signaling is central to pathogenesis of type 2 diabetes. One such pathway that involves phosphorylation and signaling via the members of the insulin-receptor substrate (IRS) family of proteins will be the focus of the present discussion, since it is particularly relevant to insulin-mediated glucose metabolism and crosstalk with inflammatory pathways. 4 Phosphorylation of tyrosine (tyr) residues of IRS-1 upon activation of the insulin receptor constitutes a critical step in the transmission of the insulin signal to downstream effectors and biological outcomes. Several laboratories have demonstrated that insulin-stimulated tyr phosphorylation of IRS-1 as well as other proximal substrates of the insulin receptor is reduced in obesity, and such reduction is believed to be at the core of the development of insulin resistance. 5 We and others have shown that the proinflammatory cytokine tumor necrosis factor alpha (TNF-a), which promotes insulin resistance in several insulin-responding cells and tissues, inhibits tyr phosphorylation of IRS-1 resulting in a state reminiscent of type 2 diabetes and obesity. 6 Interestingly, the same phenomenon is observed in the presence of an increase in intracellular fatty acids, 7 which also promote insulin resistance, showing that both cytokines and fatty acids may act via common pathways to block insulin action. Under these conditions, cytokines and fatty acids stimulate phosphorylation of IRS-1 on its serine (ser) residues. [8] [9] [10] In contrast to tyr phosphorylation, which results in the transmission of the insulin signal, ser phosphorylation blunts insulin signaling. [8] [9] [10] In experimental systems, when ser phosphorylation is prevented, the deleterious action of TNF-a and possibly fatty acids on insulin signaling might be prevented as well, further indicating the critical importance of this modification in insulin-resistant states. We and others have been investigating the molecular basis and functional consequences of IRS-1 ser phosphorylation and the responsible kinase(s). The inhibition of insulin signaling by TNF-a and fatty acids in adipocytes and hepatocytes involves activation of a kinase utilizing IRS-1 as a substrate. 8, 9 Once serine is phosphorylated, IRS-1 becomes a poor substrate for the insulin receptor, and preventing such serine phosphorylation restores IRS-1-mediated insulin receptor signaling in vitro. Of physiological significance is the fact that in obesity and type 2 diabetes, such an inhibitory phosphorylation of IRS-1 exists, in the adipocyte and also in other metabolically important tissues. 6 However, the identification of this kinase(s) and of its site(s) of action on IRS-1 has been difficult due to the presence of multiple phosphorylation sites on IRS-1, the existence in cells of multiple distinct kinases that can act on IRS in vitro, 4 and by the fact that TNF-a-mediated phosphorylation of IRS-1 is a relatively weak phenomenon and therefore uneasy to quantify. 8, 9, 11 Despite such constraints, recent work has shed light on IRS-1 phosphorylation sites as well as kinases relevant to insulin resistance. Among others, biochemical analysis has led to the identification of several serine phosphorylation sites on IRS-1, of which ser-307 appears to be of major importance and targeted by c-Jun N-terminal kinase (JNK) in vitro. 10 In cell-based systems and whole animals, JNK serves as a sensing juncture for cellular stress and the inflammatory status. 12 JNK also phosphorylates IRS-1 at the ser-307 site robustly. It is likely that other sites are also targeted by this kinase, some simultaneously with serine 307, some depending on the stimulus and context. Phosphorylation of IRS-1 at ser-307 inhibits tyrosine phosphorylation, thereby inactivating further transmission of the insulin signal. Serine phosphorylation can also be involved in the targeting of IRS-1 for proteasome-mediated acute degradation under certain but not all conditions. Of relevance is the fact that JNK activity is elevated in the tissues of several obesity models, including obesity resulting from high-fat feeding and the genetic deficiency of leptin.
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In these mice, there is also elevation of ser-307 phosphorylation of IRS-1 and decreased tyrosine phosphorylation upon insulin stimulation. These observations indicated that JNK might be a key molecule leading to insulin resistance and type 2 diabetes. This was tested and validated in models where obesity is generated in genetic deficiency of JNK isoforms, JNK1 and JNK2. 12 The JNK1 and JNK2 isoforms are expressed in most tissues at different levels and ratios, whereas JNK3 is primarily present in the central nervous system. 13 In experiments with complete deficiency of JNK1 or JNK2, most of the obesity-related increase in JNK activity and the metabolic consequences are attributable to the JNK1 isoform. 12 JNK1 knockout mice gain less weight when fed either a regular low-fat diet or a high-fat diet. Compared to wild-type mice, adipose tissue of the JNK1À/À mice is morphologically normal, with smaller adipocytes, and the liver contains dramatically less fat. Overall, there is a 10% reduction in total body adipose mass in JNK1À/À compared to wild-type controls with no alterations in the lean body mass. 12 Other tissues do not appear to be affected by lack of JNK1. Interestingly, the volumes of subcutaneous and visceral but not gonadal fat depots are reduced in JNK1À/À mice. Plasma levels of adiponectin are increased while those of resistin are reduced in JNK1-deficient mice on a high-fat diet. 12 JNK1 deficiency also dramatically enhances insulin sensitivity and confers protection against diet-induced insulin resistance as well as insulin resistance associated with the ob/ob model of genetic obesity, 12 although to a lesser extent in the latter. It may seem counterintuitive at first glance that the improvement in insulin sensitivity, which should increase the anabolic action of insulin, leads instead to reduced fat accretion. The reasons for such an effect remain elusive at this time but suggest that the impact of the JNK pathway on insulin action is not dependent on its potentially distinct effects on whole-body adiposity. The physiological relevance of the JNK1 isoform is further illustrated by the fact that it is specifically increasedFin liver, adipose tissue and skeletal muscleFin obesity resulting in increased total JNK activity and increased IRS-1 serine phosphorylation at these sites. 12 In JNK1-deficient mice, obesity-related ser-307 phosphorylation of IRS-1 is substantially reduced demonstrating that JNK1 is the predominant ser kinase activity in obesity acting on IRS-1. 12 Both TNF-a and fatty acids increase JNK1 activity as well as ser phosphorylation of IRS-1, and ser-307 phosphorylation is reduced in JNK1 knockout mice. It must be mentioned that JNK1 is not likely to be the sole serine kinase involved in the development of insulin resistance. Several studies have indeed underlined the importance of other kinases such as protein kinase c (PKC) and IkK. 14, 15 The interactions between these various kinases is complex and understanding of these networks and mechanisms remain incomplete. 16 The above discussion has focused on findings in cultured cells and murine models, but there is evidence that JNK might be highly relevant to human health. Indeed, human mutations in the gene coding for JNK-binding protein, a natural inhibitor of JNK activity, causes type 2 diabetes. 17 It is therefore not unreasonable to suggest that increased JNK activity more generally plays a role in the development of insulin resistance and type 2 diabetes in humans. If JNK inhibitors turn out to be effective in improving insulin sensitivity as much as gene targeting in experimental models, they may offer attractive possibilities of developing effective means for the treatment of human insulin resistance. I should like to conclude this review with some thoughts regarding the evolutionary reasons and advantages of the remarkable overlap and correlations between the metabolic and inflammatory signaling pathways. To this end, I will allude to the fruit fly Drosophila melanogaster. This lowly and distant cousin of ours bears a rather unique organ, called the fat body, which functions at once as liver and hematopoietic/immune system. 18 This site also appears as the mammalian homologue of adipose tissue. 19 Remarkably, the GATA family of transcription factors, which influences adipocyte differentiation in mammals, is involved in the development of the fat body of Drosophila. 19 In the course of evolution, the individualization of the hepatic, adipose and hematopoietic/immune organs occurred, while the function of a common network of functional and molecular pathways were retained in all. This might explain why there are so many overlapping pathways in the hepatocyte, adipocyte, macrophage and lymphocyte. The same molecules assume both metabolic and inflammatory roles. Depending on the cell type, the action of these overlapping pathways will produce end points, such as insulin resistance (adipocyte), atherosclerosis (macrophage) or hyperlipidemia (hepatocyte).
What could be the selective advantage of such a strong overlap between metabolic and inflammatory signaling pathways? One such advantage is that a strong immune response confers higher odds of surviving infection, and would therefore have been favored by natural selection. At the same time however, in absence of starvation, a strong immune response primes the system for an equally strong metabolic response (eg insulin resistance) to stimuli such as a high-energy and -fat intake. A survival advantage in hard times hence becomes deleterious in times of plenty.
